title: Effect of interferon therapy on human papillomavirus copy number in patients with Condyloma acuminatum.
abstract: Interferons exert antiviral, antiproliferative, and immunomodulatory effects on target cells. The effectiveness of interferon treatment can be followed by measuring parameters involved in interferon action. The clinical effectiveness of interferons has been proved in the human papillomavirus (HPV)-associated disease condyloma acuminatum. Because one of the most important goals in the treatment of this condition is the elimination of recurrences, it was asked whether clinically effective interferon therapy was associated with elimination of HPV DNA. The authors used a polymerase chain reaction-based method to detect the HPV from minute amounts of clinical biopsies. Human papillomavirus-transformed cell lines or cloned HPV genomes served as different copy number controls. The intensity ratio of L1 HPV and the human beta-globin (which served as an internal control) fragments was determined and used for estimation of HPV copy number in different biopsies. A direct effect of interferon treatment on HPV viral genome copies was observed in a group of responder patients, but not in the clinically resistant group. With these data, a correlation was found between virologic data and clinical findings. This method also can be used in other lesions to determine the HPV copy number and HPV type and may have value in determining the antiviral activities of other agents used in the treatment of HPV-related lesions.
authors.affiliation: Department of Microbiology, University of Texas Medical Branch, Galveston 77555-1019, USA.
authors.forename: I
authors.initials: I
authors.lastname: Arany
authors.forename: P
authors.initials: P
authors.lastname: Rady
authors.forename: S K
authors.initials: SK
authors.lastname: Tyring
mesh_terms: D002460:Cell Line; D003218:Condylomata Acuminata / Q000188:drug therapy* / Q000235:genetics; D004279:DNA, Viral / Q000187:drug effects; D018628:Gene Dosage; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D027383:Papillomaviridae / Q000235:genetics* / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000188:drug therapy* / Q000235:genetics; D016133:Polymerase Chain Reaction; D012307:Risk Factors; D017193:Skin Diseases, Viral / Q000188:drug therapy / Q000235:genetics; D014412:Tumor Virus Infections / Q000188:drug therapy* / Q000235:genetics
chemical_list: D004279:DNA, Viral; D007372:Interferons